All News

The competition to lure biotech investors and know-how is heating up in US states - and so are the legal battles between over fair and unfair incentives.

Retina Implant AG has developed an electronic chip that is implanted in the eye under the retina and could restore partial vision for the blind – and is now looking for funding from investors to take the product to the market next year.

Friedrich Bornikoel, managing partner for TVM Capital's Information & Communications Technology group, sees a recovery in German venture capital - but still no boom.

Look out for more competition from Asia as Singapore turns on the pressure with its own increase in R&D spending.

BioXell, an Italian spin-out from Roche, said it has raised €10.5 million in funding from an extension of its Series C round which was first closed in October, 2004. TVM Capital, one of Germany’s biggest venture capital funds, led the financing.

The notion of grid computing is seeping out of the academic world into business applications.

Save energy, cool your seat.

We stray from the usual stuff of R&D to report on a development that will doubtless appeal to those sad souls who are preparing for World Cup fever.

The OECD has come up with a report that spells out a new "agreed set of Guidelines for the Licensing of Genetic Inventions used in healthcare".

On March 7 in Paris, we open our Science|Business Roundtable of leaders in European industry and academia, to debate and propose new ideas to improve the climate for innovation in Europe. One immediate suggestion is that Europeans do better at communications.

Scientists at Innsbruck Medical University have performed a great service to mankind by demonstrating that beer has important health-promoting properties.

The buzz surrounding mobile TV is spurring cross-industry partnerships and attracting significant amounts of venture capital. But can 3G networks stand the pace?

JADO Technologies, a spin-out from the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, is developing small molecules that target cell membrane receptors, opening up a potential new avenue for drug delivery.

Philippe Pouletty is a man with a mission - to make France synonymous with biotechnology. He has his work cut out...